Company intelligence / Profile preview

Royal Biotek

Düsseldorf, Germany

Ownership: Private
Development stage: Other

Overview

Royal Biotech is a global medical technology company specializing in the development and manufacturing of advanced diagnostic systems and point-of-care testing (POCT) solutions. The company provides a wide range of products including rapid diagnostic kits for infectious diseases, food safety testing, and environmental monitoring tools. Their core technology focuses on biosensors and automated diagnostic platforms designed for high sensitivity and ease of use in clinical and field settings. Royal Biotech serves healthcare providers, laboratories, and industrial clients worldwide with a focus on improving public health through rapid detection.

Therapeutic areas: Infectious DiseasesOther
Modalities: Diagnostic kitPoint-of-care testingBiosensor
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Royal Biotek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Royal Biotek.

Explore the full profile